SlideShare a Scribd company logo
SEPSIS
PRESENTER: WONG SHIN YIING
SUPERVISOR: DR LYDIA / DR JEE
HISTORY OF SEPSIS
• Recognition of sepsis changed markedly over time
• 4th century BC - Hippocrates was the first to use the term sipsi
(Greek for make rotten)
• Discoveries of microorganism
• Development of germ theory of disease
• 1989 - Dr Roger C. Bone published a paper described sepsis as a state of
invasion of microorganism into blood stream and its clinical complication
EVOLUTION OF SEPSIS DEFINITIONS
1991
2001
2016
SEPSIS -1 :
INFECTION + SIRS
= SEPSIS
SEPSIS-2:
SURVIVING SEPSIS
CAMPAIGN
SEPSIS -3 :
q-SOFA
INFECTION SIRS SEPSIS
SEPSIS-1 DEFINITION (1991)
• American College of Chest Physician (ACCP) and Society of Critical Care Medicine (SCCM)
SEPSIS -2 DEFINITION (2001)
• International Sepsis Definitions Conference
• American College of Chest Physician (ACCP), Society of Critical Care Medicine (SCCM), American
Thoracic Society (ATS), European Society of Intensive Care Medicine (ESICM) and Surgical
Infection Society (SIS)
INFECTION SIRS SEPSIS
Expanded
criteria:
General
Inflammatory
Hemodynamic
Tissues
perfusion
INFECTION
≥2 SOFA/
q-SOFA
SEPSIS
SEPSIS -3 DEFINITION (2016)
• Life threatening organ dysfunction due to a dysregulated host response to
infection
• Clinical criteria – organ dysfunction is defined as an increase of 2 points or
more in the Sequential Organ Failure Assessment score (SOFA)
SEPSIS -3 DEFINITION (2016)
Septic Shock
• Subset of sepsis in which underlying circulatory and cellular / metabolic
abnormalities are profound enough to substantially increase mortality
• Clinical criteria – sepsis and (despite adequate volume resuscitation) both of :
persistent hypotension requiring vasopressors to maintain MAP greater than or
equal to 65 mmHg, and lactate greater than 2 mmol/L
RISK FACTOR
• Age – infant and old age
• Gender - Males are 25% to 30% more likely to develop sepsis than females
• Ethnicity/ race
• Genetics - Interleukin 1β-511 homozygosity is increased risk of mortality from sepsis
• Factors that breach natural barriers to pathogen invasion or compromise immune function:
• Recent surgery or hospitalization
• Indwelling urinary catheters, intravascular access devices, endotracheal tubes
• Malnutrition
• Burns and/or trauma
• Chronic illness (eg, cancer, diabetes)
• Immunosuppression
• IVDU
• Pregnancy or recent childbirth, miscarriage, or termination of pregnancy
PATHOPHYSIOLOGY OF
SEPSIS
NORMAL RESPONSE TO INFECTION
• The host response to infection starts when innate immune cells like macrophages recognize
and binds to microbial components.
This can occur by:
• Pattern Recognition Receptors (PRR) on host cells which bind to Pathogen Associated
Molecular Patterns (PAMP) in microbes
• PRR include Toll Like Receptors (TLR) and nucleotide-binding oligomerization domain-like
receptors (NOD)-like receptors (NLRs)
• PRR can also recognize endogenous signals such as danger-associated molecular patterns
(DAMPs) that are released during the inflammatory insult.
• DAMPs are nuclear, cytoplasmic, or mitochondrial structures acquiring new functions when
released in the extracellular environment.
NORMAL RESPONSE TO INFECTION
• Binding of host immune cell receptors to microbial components causes polymorphonuclear
leukocytes (PMNs) become activated and express adhesion molecules that cause aggregation
and margination to the vascular endothelium.
• The release of mediators by PMNs at the site of infection is responsible for the cardinal signs
of local inflammation: warmth and erythema due to local vasodilation and hyperaemia, and
protein-rich oedema due to increased microvascular permeability
• The balance of pro-inflammatory and anti-inflammatory mediators regulates the inflammatory
processes, including adherence, chemotaxis, phagocytosis of invading bacteria, bacterial killing,
and phagocytosis of debris from injured tissue.
• If the mediators balance each other and the initial infectious insult is overcome, homeostasis
will be restored. The end result will be tissue repair and healing.
TRANSITION TO SEPSIS
• Sepsis occurs when the release of pro-inflammatory mediators in response to an infection
exceeds the boundaries of the local environment, leading to a more generalized response.
• This causes decreased oxygen utilization associated with mitochondrial dysfunction rather
than or in addition to poor oxygen delivery to tissues.
• The cellular injury, accompanied by the release of pro-inflammatory and anti-inflammatory
mediators, often progresses to organ dysfunction and leads to high mortality.
WHY WOULD AN IMMUNE RESPONSE
SPREAD BEYOND AN INFECTIOUS POINT?
EFFECTS OF MICROORGANISM
• Endotoxins (LPS) found in gram
negative organisms.
• Caused release of pro
inflammatory cytokines (TNF-a
and IL-1)
• Stimulate activation of
coagulation and fibrinolysis
leads to thrombosis.
COMPLEMENT ACTIVATION
• Protein cascade, which
promoting, and coordinating
inflammation response.
• Regulate btw innate and
adaptive immunity.
• When pathogen escaped from
being eliminate, complementary
system continue its effort by
exacerbate inflammation which
eventually leads to SIRS.
GENECTIC SUSCEPTIBILITY
• Polymorphisms in genes coding
for proteins involved in the
recognition and the response to
bacterial pathogens can
influence the amount or
function of the protein
produced in response to
bacterial stimuli.
SYSTEMIC EFFECTS OF SEPSIS
When the immune response becomes generalized during an infection, widespread cellular injury
may occur
Mechanisms proposed to explain the cellular injury include:
• Tissue ischemia (insufficient oxygen relative to oxygen need)
• Cytopathic injury (direct cell injury by pro-inflammatory mediators and/or other products of
inflammation)
• Altered rate of cell death pathways
• Activation of the coagulation system and vascular endothelium
• Hypotension due to diffuse vasodilation
• ▼ventricular performance due to release of myocardial depressant substances
• Interfere with redistribution of blood flow from splanchnic organs to core organs
(heart and brain) when oxygen delivery is depressed
CIRCULATION
• Endothelial injury ▼pulmonary
blood flow, ▲ microvascular
permeability, leads to pulmonary
edema ▶V/P mismatch, hypoxia
LUNGS
• The circulatory abnormalities in
sepsis may depress the gut's
normal barrier function
• allows translocation of bacteria
and endotoxin
GI SYSTEM
• Systemic hypotension, direct renal
vasoconstriction, release of
cytokines contribute to renal
injury
RENAL
• Liver dysfunction can prevent the
elimination of enteric-derived
endotoxin and bacteria-derived
products, which prevents the
appropriate local cytokine
response.
LIVER
• The most common CNS
complications are an altered
sensorium (encephalopathy).
• The pathogenesis of the
encephalopathy is poorly defined.
• CNS dysfunction has been
attributed to changes in
metabolism and alterations in cell
signalling due to inflammatory
mediators.
CNS
EFFECTS OF
SEPSIS
DIAGNOSTIC
PROCEDURES
HISTORY
TAKING
CLINICAL
EXAMINATION
LABORATORY
INVESTIGATION
IMAGING
SEVERITY
ASSESMENT–
SOFA/ q-SOFA
HISTORY TAKING
•Thorough and timely history focuses on symptoms, comorbidities, recent surgery, recent
antibiotic use, presence of medical devices, and travel
• Common generalized symptoms of sepsis include: fever, chills, rigors, nausea, vomiting,
lethargy, malaise, myalgia, dyspnoea
• Localizing symptoms:
• CNS: headache, photophobia, neck stiffness, seizure etc
• Respiratory: cough (chesty/ dry), runny nose, shortness of breath, pleurisy
• Abdomen: pain, diarrhoea, dysuria, haematuria, cloudy urine
• Peripheral: wounds, joint pain, swelling
•Elderly persons may have limited or nonspecific symptoms (eg, poor oral intake, inanition)
CLINICAL EXAMINATION
Physical examination focuses on detecting generalized signs of sepsis and on determining the
source.
Generalized evidence of sepsis is highly variable but commonly includes:
₋ Fever (more than 38.5°C) or hypothermia (less than 36°C)
₋ Hypotension - Presenting sign in 40% of patients with sepsis
₋ Tachycardia
₋ Tachypnoea
₋ Altered mental status; older patients may present with irritability or agitation
₋ Increased capillary refill time (more than 3 seconds)
₋ Mottled/ clammy skin
Systemic examination should be carried out thoroughly as it may uncover an unexpected site.
LABORATORY INVESTIGATION
 Full blood counts : TWC ↑, Platelets ↓, HB ↓ / ↔
 Coagulation profile
 Renal profile: Urea/ Creat ↑ (AKI)
 Liver function test: transaminitis
 Blood gas : acidosis
 Lactic acid ↑
 Biomarkers: CRP, PCT
 Microbiology: Blood cultures, Urine cultures, Sputum cultures
 Urine dipstick : look for UTI
Biomarkers for sepsis
• May be used for early diagnosis of sepsis, to predict outcome and to guide the choice of
antibiotic therapy.
• Many potential biomarkers have been evaluated – CRP and PCT remain the most commonly
used and widely available.
• To date, no single ideal biomarker for sepsis hence a combination of biomarkers + clinical
assessment are used for early Dx and better risk assessment.
C- REACTIVE PROTEIN:
Produced in the liver in response to infection
and/or inflammation.
Increase within 4-8H of inflammatory stimulus
and peak after 36-72 H
Slowly normalise
Low specificity – drawback as biomarker of
sepsis in adults.
PROCALCITONIN:
Released in parenchymal cells in response to
bacterial toxins
Increase within 2-4H of inflammatory stimulus
and peak after 8-24 H
Normalise quick with patient in recovery
Levels are slightly elevated in severe parasite
and fungal infections
Levels are low in viral diseases
Imaging
₋ Radiography:
₋ Chest: pneumonia/ tuberculosis/ effusions / mass or lesions
₋ Abdomen: perforation / stones etc
₋ Ultrasonography
₋ Abdominal ultrasonography is used to identify abdominal infections (eg, appendicitis, cholecystitis,
pancreatitis)
₋ Renal ultrasonography is used to identify renal obstruction or pyelonephritis
₋CT:
₋ CT of abdomen and pelvis to identify abdominal or pelvic abscesses (eg, pancreatic abscess, renal
abscess) or ischemic bowel
₋ CT may also be used to determine depth and extent of some serious soft tissue infections (eg,
necrotizing fasciitis)
₋ MRI of brain and/or spine is used in evaluation of meningitis, encephalitis, and epidural abscess
MANAGEMENT OF
SEPSIS
INITIAL RESUSCITATION
•At least 30 mL/kg of intravenous (IV) crystalloid fluid should be given within the first 3 h of
resuscitation
•To avoid over- and under-resuscitation, fluid administration beyond the initial resuscitation
should be guided by careful assessment of intravascular volume status and organ perfusion.
•Dynamic parameters include response to a passive leg raise or a fluid bolus, using stroke
volume (SV), stroke volume variation (SVV), pulse pressure variation (PPV), or
echocardiography, should be use to assess fluid responsiveness.
•Serum lactate is an important biomarker of tissue hypoxia and dysfunction. It was suggested to
decrease serum lactate in patients with elevated lactate level.
•Capillary refill time to guide resuscitation as an adjunct to other measures of perfusion.
HEMODYNAMIC MANAGEMENT
•Keep MAP > 65mmHg
• Crystalloid as first line fluid for resuscitation.
• To start vasopressor early.
•Delay in initiation of vasopressor therapy was
associated with an increased mortality risk.
• Avoid overload. Faster achieving target MAP,
preventing onset or progress of organ
dysfunction.
• Noradrenaline as first line agent. Epinephrine as
second line.
5 fundamental questions to assessment
of hemodynamic:
1. Should I give more fluids?
- Stroke volume variation
- Pulse pressure analysis
2. Is giving more fluid harmful?
- ultrasonography of lungs
3. Is inotrope needed?
4. Is vasoactive agent needed?
- Continuous oesophageal Doppler
- Velocity time integral (VTI) of left ventricular
outflow tract (LVOT)
- Passive leg raising test
5. Is the organ/ tissue perfusion adequate?
- Capillary refill time
- Serum lactate
- Mottling score
ICU
Delayed admissions of critically ill patients
from ED are associated with decreased
sepsis bundle compliance and increased
mortality, ventilator duration, and ICU and
hospital length of stay
VENTILATION
CONCLUSION
• Sepsis is a life-threatening organ dysfunction due to a dysregulated host response to infection.
• Sepsis and septic shock are medical emergencies, treatment should be started immediately
upon recognition.
•Initial resuscitation and antibiotics should be given within 1 hour (infection present)
•Adequate fluid resuscitation and early starting of vasopressor to prevent overloading and
achieve target MAP faster.
• Keep MAP > 65 mmHg
•ICU admission within 6 hours is recommended.

More Related Content

What's hot

Sepsis 3.0
Sepsis 3.0Sepsis 3.0
Sepsis 3.0
Dhananjay Gupta
 
RCEM Paediatric Sepsis Talk
RCEM Paediatric Sepsis TalkRCEM Paediatric Sepsis Talk
RCEM Paediatric Sepsis Talk
Jeremy Tong
 
Sepsis 2016
Sepsis 2016 Sepsis 2016
Sepsis 2016
Subhankar Chatterjee
 
Sepsis 2017
Sepsis 2017Sepsis 2017
Sepsis 2017
Badheeb
 
Sepsis 3
Sepsis 3Sepsis 3
Sepsis 3
Shikha Panwar
 
Sepsis
SepsisSepsis
Sepsis
Shibinath VM
 
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
Abdullatif Al-Rashed
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
Ramadan Arafa
 
Sepsis update 2021
Sepsis update 2021Sepsis update 2021
Sepsis update 2021
KTD Priyadarshani
 
Sepsis – pathophysiology and management
Sepsis – pathophysiology and managementSepsis – pathophysiology and management
Sepsis – pathophysiology and managementVidhi Singh
 
SEPSIS.pptx
SEPSIS.pptxSEPSIS.pptx
SEPSIS.pptx
Kanika Chaudhary
 
Sepsis definition
Sepsis definitionSepsis definition
Sepsis definition
Irvan Setiawan
 
Understanding Lactate - Paul Marik
Understanding Lactate - Paul Marik Understanding Lactate - Paul Marik
Understanding Lactate - Paul Marik
SMACC Conference
 
Sepsis
SepsisSepsis
Fluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patientsFluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patientsUbaidur Rahaman
 
Sepsis In critical care 2019 final
Sepsis In critical care 2019 finalSepsis In critical care 2019 final
Sepsis In critical care 2019 final
Fadel Omar
 
Anesthesia for Trauma
Anesthesia for Trauma Anesthesia for Trauma
Anesthesia for Trauma
Saeid Safari
 
ANAESTHETIC CONSIDERATIONS IN AIDS PATIENTS
ANAESTHETIC CONSIDERATIONS IN AIDS PATIENTSANAESTHETIC CONSIDERATIONS IN AIDS PATIENTS
ANAESTHETIC CONSIDERATIONS IN AIDS PATIENTS
Selva Kumar
 
Management of cytokine storm during Covid 19
Management of cytokine storm during Covid 19Management of cytokine storm during Covid 19
Management of cytokine storm during Covid 19
Dr.Mahmoud Abbas
 

What's hot (20)

Sepsis And Septic Shock
Sepsis And Septic ShockSepsis And Septic Shock
Sepsis And Septic Shock
 
Sepsis 3.0
Sepsis 3.0Sepsis 3.0
Sepsis 3.0
 
RCEM Paediatric Sepsis Talk
RCEM Paediatric Sepsis TalkRCEM Paediatric Sepsis Talk
RCEM Paediatric Sepsis Talk
 
Sepsis 2016
Sepsis 2016 Sepsis 2016
Sepsis 2016
 
Sepsis 2017
Sepsis 2017Sepsis 2017
Sepsis 2017
 
Sepsis 3
Sepsis 3Sepsis 3
Sepsis 3
 
Sepsis
SepsisSepsis
Sepsis
 
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
 
Sepsis update 2021
Sepsis update 2021Sepsis update 2021
Sepsis update 2021
 
Sepsis – pathophysiology and management
Sepsis – pathophysiology and managementSepsis – pathophysiology and management
Sepsis – pathophysiology and management
 
SEPSIS.pptx
SEPSIS.pptxSEPSIS.pptx
SEPSIS.pptx
 
Sepsis definition
Sepsis definitionSepsis definition
Sepsis definition
 
Understanding Lactate - Paul Marik
Understanding Lactate - Paul Marik Understanding Lactate - Paul Marik
Understanding Lactate - Paul Marik
 
Sepsis
SepsisSepsis
Sepsis
 
Fluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patientsFluid responsiveness in critically ill patients
Fluid responsiveness in critically ill patients
 
Sepsis In critical care 2019 final
Sepsis In critical care 2019 finalSepsis In critical care 2019 final
Sepsis In critical care 2019 final
 
Anesthesia for Trauma
Anesthesia for Trauma Anesthesia for Trauma
Anesthesia for Trauma
 
ANAESTHETIC CONSIDERATIONS IN AIDS PATIENTS
ANAESTHETIC CONSIDERATIONS IN AIDS PATIENTSANAESTHETIC CONSIDERATIONS IN AIDS PATIENTS
ANAESTHETIC CONSIDERATIONS IN AIDS PATIENTS
 
Management of cytokine storm during Covid 19
Management of cytokine storm during Covid 19Management of cytokine storm during Covid 19
Management of cytokine storm during Covid 19
 

Similar to sepsis.pptx

Sepsis
SepsisSepsis
Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.
AngelGovekar
 
Pathophysiology and management of septic shock-1.pptx
Pathophysiology and management of septic shock-1.pptxPathophysiology and management of septic shock-1.pptx
Pathophysiology and management of septic shock-1.pptx
niyigok
 
SEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptxSEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptx
Lando Elvis
 
SESPSIS & SEPTIC SHOCK
SESPSIS & SEPTIC SHOCKSESPSIS & SEPTIC SHOCK
SESPSIS & SEPTIC SHOCK
GovtRoyapettahHospit
 
SEPSIS.pptx
SEPSIS.pptxSEPSIS.pptx
SEPSIS.pptx
Lasith Dilshan
 
sepsis
sepsissepsis
sepsis and septic shock: A 600L MBBS lecture
sepsis and septic shock: A 600L MBBS lecturesepsis and septic shock: A 600L MBBS lecture
sepsis and septic shock: A 600L MBBS lecture
Igbashio
 
Lupus and interstitial nephritis.pptx
Lupus and interstitial nephritis.pptxLupus and interstitial nephritis.pptx
Lupus and interstitial nephritis.pptx
Rakhipanwar1
 
Sepsis
SepsisSepsis
Sepsis
Jwan AlSofi
 
sepsis
 sepsis sepsis
Sepsis syndrome
Sepsis syndromeSepsis syndrome
Sepsis syndrome
Efosa Aimien
 
SLE PRESENTATION presentatiomn (1).pptx
SLE PRESENTATION presentatiomn   (1).pptxSLE PRESENTATION presentatiomn   (1).pptx
SLE PRESENTATION presentatiomn (1).pptx
shasshankk12345
 
Approach to infectious disease.pptx
Approach to infectious disease.pptxApproach to infectious disease.pptx
Approach to infectious disease.pptx
Krishn Undaviya
 
Lupus nephritis 2016
Lupus nephritis 2016Lupus nephritis 2016
Lupus nephritis 2016
drsamianik
 
Sepsis
SepsisSepsis
Sepsis the serial killer
Sepsis the serial killerSepsis the serial killer
Sepsis the serial killer
Magdy Khames Aly
 
Urosepsis
UrosepsisUrosepsis
Urosepsis
dr sajid Abbasi
 
Final slides today 5 feb 13
Final slides   today 5 feb 13 Final slides   today 5 feb 13
Final slides today 5 feb 13
Pooja Goswami
 
7. Sepsis and Septic Shock.pptx
7. Sepsis and Septic Shock.pptx7. Sepsis and Septic Shock.pptx
7. Sepsis and Septic Shock.pptx
BereketTesfaye23
 

Similar to sepsis.pptx (20)

Sepsis
SepsisSepsis
Sepsis
 
Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.
 
Pathophysiology and management of septic shock-1.pptx
Pathophysiology and management of septic shock-1.pptxPathophysiology and management of septic shock-1.pptx
Pathophysiology and management of septic shock-1.pptx
 
SEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptxSEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptx
 
SESPSIS & SEPTIC SHOCK
SESPSIS & SEPTIC SHOCKSESPSIS & SEPTIC SHOCK
SESPSIS & SEPTIC SHOCK
 
SEPSIS.pptx
SEPSIS.pptxSEPSIS.pptx
SEPSIS.pptx
 
sepsis
sepsissepsis
sepsis
 
sepsis and septic shock: A 600L MBBS lecture
sepsis and septic shock: A 600L MBBS lecturesepsis and septic shock: A 600L MBBS lecture
sepsis and septic shock: A 600L MBBS lecture
 
Lupus and interstitial nephritis.pptx
Lupus and interstitial nephritis.pptxLupus and interstitial nephritis.pptx
Lupus and interstitial nephritis.pptx
 
Sepsis
SepsisSepsis
Sepsis
 
sepsis
 sepsis sepsis
sepsis
 
Sepsis syndrome
Sepsis syndromeSepsis syndrome
Sepsis syndrome
 
SLE PRESENTATION presentatiomn (1).pptx
SLE PRESENTATION presentatiomn   (1).pptxSLE PRESENTATION presentatiomn   (1).pptx
SLE PRESENTATION presentatiomn (1).pptx
 
Approach to infectious disease.pptx
Approach to infectious disease.pptxApproach to infectious disease.pptx
Approach to infectious disease.pptx
 
Lupus nephritis 2016
Lupus nephritis 2016Lupus nephritis 2016
Lupus nephritis 2016
 
Sepsis
SepsisSepsis
Sepsis
 
Sepsis the serial killer
Sepsis the serial killerSepsis the serial killer
Sepsis the serial killer
 
Urosepsis
UrosepsisUrosepsis
Urosepsis
 
Final slides today 5 feb 13
Final slides   today 5 feb 13 Final slides   today 5 feb 13
Final slides today 5 feb 13
 
7. Sepsis and Septic Shock.pptx
7. Sepsis and Septic Shock.pptx7. Sepsis and Septic Shock.pptx
7. Sepsis and Septic Shock.pptx
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 

Recently uploaded (20)

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 

sepsis.pptx

  • 1. SEPSIS PRESENTER: WONG SHIN YIING SUPERVISOR: DR LYDIA / DR JEE
  • 2. HISTORY OF SEPSIS • Recognition of sepsis changed markedly over time • 4th century BC - Hippocrates was the first to use the term sipsi (Greek for make rotten) • Discoveries of microorganism • Development of germ theory of disease • 1989 - Dr Roger C. Bone published a paper described sepsis as a state of invasion of microorganism into blood stream and its clinical complication
  • 3. EVOLUTION OF SEPSIS DEFINITIONS 1991 2001 2016 SEPSIS -1 : INFECTION + SIRS = SEPSIS SEPSIS-2: SURVIVING SEPSIS CAMPAIGN SEPSIS -3 : q-SOFA
  • 4. INFECTION SIRS SEPSIS SEPSIS-1 DEFINITION (1991) • American College of Chest Physician (ACCP) and Society of Critical Care Medicine (SCCM)
  • 5.
  • 6. SEPSIS -2 DEFINITION (2001) • International Sepsis Definitions Conference • American College of Chest Physician (ACCP), Society of Critical Care Medicine (SCCM), American Thoracic Society (ATS), European Society of Intensive Care Medicine (ESICM) and Surgical Infection Society (SIS) INFECTION SIRS SEPSIS Expanded criteria: General Inflammatory Hemodynamic Tissues perfusion
  • 7.
  • 8. INFECTION ≥2 SOFA/ q-SOFA SEPSIS SEPSIS -3 DEFINITION (2016) • Life threatening organ dysfunction due to a dysregulated host response to infection • Clinical criteria – organ dysfunction is defined as an increase of 2 points or more in the Sequential Organ Failure Assessment score (SOFA)
  • 9. SEPSIS -3 DEFINITION (2016) Septic Shock • Subset of sepsis in which underlying circulatory and cellular / metabolic abnormalities are profound enough to substantially increase mortality • Clinical criteria – sepsis and (despite adequate volume resuscitation) both of : persistent hypotension requiring vasopressors to maintain MAP greater than or equal to 65 mmHg, and lactate greater than 2 mmol/L
  • 10.
  • 11. RISK FACTOR • Age – infant and old age • Gender - Males are 25% to 30% more likely to develop sepsis than females • Ethnicity/ race • Genetics - Interleukin 1β-511 homozygosity is increased risk of mortality from sepsis • Factors that breach natural barriers to pathogen invasion or compromise immune function: • Recent surgery or hospitalization • Indwelling urinary catheters, intravascular access devices, endotracheal tubes • Malnutrition • Burns and/or trauma • Chronic illness (eg, cancer, diabetes) • Immunosuppression • IVDU • Pregnancy or recent childbirth, miscarriage, or termination of pregnancy
  • 13. NORMAL RESPONSE TO INFECTION • The host response to infection starts when innate immune cells like macrophages recognize and binds to microbial components. This can occur by: • Pattern Recognition Receptors (PRR) on host cells which bind to Pathogen Associated Molecular Patterns (PAMP) in microbes • PRR include Toll Like Receptors (TLR) and nucleotide-binding oligomerization domain-like receptors (NOD)-like receptors (NLRs) • PRR can also recognize endogenous signals such as danger-associated molecular patterns (DAMPs) that are released during the inflammatory insult. • DAMPs are nuclear, cytoplasmic, or mitochondrial structures acquiring new functions when released in the extracellular environment.
  • 14.
  • 15. NORMAL RESPONSE TO INFECTION • Binding of host immune cell receptors to microbial components causes polymorphonuclear leukocytes (PMNs) become activated and express adhesion molecules that cause aggregation and margination to the vascular endothelium. • The release of mediators by PMNs at the site of infection is responsible for the cardinal signs of local inflammation: warmth and erythema due to local vasodilation and hyperaemia, and protein-rich oedema due to increased microvascular permeability • The balance of pro-inflammatory and anti-inflammatory mediators regulates the inflammatory processes, including adherence, chemotaxis, phagocytosis of invading bacteria, bacterial killing, and phagocytosis of debris from injured tissue. • If the mediators balance each other and the initial infectious insult is overcome, homeostasis will be restored. The end result will be tissue repair and healing.
  • 16.
  • 17. TRANSITION TO SEPSIS • Sepsis occurs when the release of pro-inflammatory mediators in response to an infection exceeds the boundaries of the local environment, leading to a more generalized response. • This causes decreased oxygen utilization associated with mitochondrial dysfunction rather than or in addition to poor oxygen delivery to tissues. • The cellular injury, accompanied by the release of pro-inflammatory and anti-inflammatory mediators, often progresses to organ dysfunction and leads to high mortality.
  • 18.
  • 19.
  • 20. WHY WOULD AN IMMUNE RESPONSE SPREAD BEYOND AN INFECTIOUS POINT? EFFECTS OF MICROORGANISM • Endotoxins (LPS) found in gram negative organisms. • Caused release of pro inflammatory cytokines (TNF-a and IL-1) • Stimulate activation of coagulation and fibrinolysis leads to thrombosis. COMPLEMENT ACTIVATION • Protein cascade, which promoting, and coordinating inflammation response. • Regulate btw innate and adaptive immunity. • When pathogen escaped from being eliminate, complementary system continue its effort by exacerbate inflammation which eventually leads to SIRS. GENECTIC SUSCEPTIBILITY • Polymorphisms in genes coding for proteins involved in the recognition and the response to bacterial pathogens can influence the amount or function of the protein produced in response to bacterial stimuli.
  • 21.
  • 22. SYSTEMIC EFFECTS OF SEPSIS When the immune response becomes generalized during an infection, widespread cellular injury may occur Mechanisms proposed to explain the cellular injury include: • Tissue ischemia (insufficient oxygen relative to oxygen need) • Cytopathic injury (direct cell injury by pro-inflammatory mediators and/or other products of inflammation) • Altered rate of cell death pathways • Activation of the coagulation system and vascular endothelium
  • 23. • Hypotension due to diffuse vasodilation • ▼ventricular performance due to release of myocardial depressant substances • Interfere with redistribution of blood flow from splanchnic organs to core organs (heart and brain) when oxygen delivery is depressed CIRCULATION • Endothelial injury ▼pulmonary blood flow, ▲ microvascular permeability, leads to pulmonary edema ▶V/P mismatch, hypoxia LUNGS • The circulatory abnormalities in sepsis may depress the gut's normal barrier function • allows translocation of bacteria and endotoxin GI SYSTEM • Systemic hypotension, direct renal vasoconstriction, release of cytokines contribute to renal injury RENAL • Liver dysfunction can prevent the elimination of enteric-derived endotoxin and bacteria-derived products, which prevents the appropriate local cytokine response. LIVER • The most common CNS complications are an altered sensorium (encephalopathy). • The pathogenesis of the encephalopathy is poorly defined. • CNS dysfunction has been attributed to changes in metabolism and alterations in cell signalling due to inflammatory mediators. CNS EFFECTS OF SEPSIS
  • 26. HISTORY TAKING •Thorough and timely history focuses on symptoms, comorbidities, recent surgery, recent antibiotic use, presence of medical devices, and travel • Common generalized symptoms of sepsis include: fever, chills, rigors, nausea, vomiting, lethargy, malaise, myalgia, dyspnoea • Localizing symptoms: • CNS: headache, photophobia, neck stiffness, seizure etc • Respiratory: cough (chesty/ dry), runny nose, shortness of breath, pleurisy • Abdomen: pain, diarrhoea, dysuria, haematuria, cloudy urine • Peripheral: wounds, joint pain, swelling •Elderly persons may have limited or nonspecific symptoms (eg, poor oral intake, inanition)
  • 27. CLINICAL EXAMINATION Physical examination focuses on detecting generalized signs of sepsis and on determining the source. Generalized evidence of sepsis is highly variable but commonly includes: ₋ Fever (more than 38.5°C) or hypothermia (less than 36°C) ₋ Hypotension - Presenting sign in 40% of patients with sepsis ₋ Tachycardia ₋ Tachypnoea ₋ Altered mental status; older patients may present with irritability or agitation ₋ Increased capillary refill time (more than 3 seconds) ₋ Mottled/ clammy skin Systemic examination should be carried out thoroughly as it may uncover an unexpected site.
  • 28. LABORATORY INVESTIGATION  Full blood counts : TWC ↑, Platelets ↓, HB ↓ / ↔  Coagulation profile  Renal profile: Urea/ Creat ↑ (AKI)  Liver function test: transaminitis  Blood gas : acidosis  Lactic acid ↑  Biomarkers: CRP, PCT  Microbiology: Blood cultures, Urine cultures, Sputum cultures  Urine dipstick : look for UTI
  • 29.
  • 30.
  • 31.
  • 32. Biomarkers for sepsis • May be used for early diagnosis of sepsis, to predict outcome and to guide the choice of antibiotic therapy. • Many potential biomarkers have been evaluated – CRP and PCT remain the most commonly used and widely available. • To date, no single ideal biomarker for sepsis hence a combination of biomarkers + clinical assessment are used for early Dx and better risk assessment. C- REACTIVE PROTEIN: Produced in the liver in response to infection and/or inflammation. Increase within 4-8H of inflammatory stimulus and peak after 36-72 H Slowly normalise Low specificity – drawback as biomarker of sepsis in adults. PROCALCITONIN: Released in parenchymal cells in response to bacterial toxins Increase within 2-4H of inflammatory stimulus and peak after 8-24 H Normalise quick with patient in recovery Levels are slightly elevated in severe parasite and fungal infections Levels are low in viral diseases
  • 33. Imaging ₋ Radiography: ₋ Chest: pneumonia/ tuberculosis/ effusions / mass or lesions ₋ Abdomen: perforation / stones etc ₋ Ultrasonography ₋ Abdominal ultrasonography is used to identify abdominal infections (eg, appendicitis, cholecystitis, pancreatitis) ₋ Renal ultrasonography is used to identify renal obstruction or pyelonephritis ₋CT: ₋ CT of abdomen and pelvis to identify abdominal or pelvic abscesses (eg, pancreatic abscess, renal abscess) or ischemic bowel ₋ CT may also be used to determine depth and extent of some serious soft tissue infections (eg, necrotizing fasciitis) ₋ MRI of brain and/or spine is used in evaluation of meningitis, encephalitis, and epidural abscess
  • 34.
  • 35.
  • 37.
  • 38. INITIAL RESUSCITATION •At least 30 mL/kg of intravenous (IV) crystalloid fluid should be given within the first 3 h of resuscitation •To avoid over- and under-resuscitation, fluid administration beyond the initial resuscitation should be guided by careful assessment of intravascular volume status and organ perfusion. •Dynamic parameters include response to a passive leg raise or a fluid bolus, using stroke volume (SV), stroke volume variation (SVV), pulse pressure variation (PPV), or echocardiography, should be use to assess fluid responsiveness. •Serum lactate is an important biomarker of tissue hypoxia and dysfunction. It was suggested to decrease serum lactate in patients with elevated lactate level. •Capillary refill time to guide resuscitation as an adjunct to other measures of perfusion.
  • 39. HEMODYNAMIC MANAGEMENT •Keep MAP > 65mmHg • Crystalloid as first line fluid for resuscitation. • To start vasopressor early. •Delay in initiation of vasopressor therapy was associated with an increased mortality risk. • Avoid overload. Faster achieving target MAP, preventing onset or progress of organ dysfunction. • Noradrenaline as first line agent. Epinephrine as second line.
  • 40. 5 fundamental questions to assessment of hemodynamic: 1. Should I give more fluids? - Stroke volume variation - Pulse pressure analysis 2. Is giving more fluid harmful? - ultrasonography of lungs 3. Is inotrope needed? 4. Is vasoactive agent needed? - Continuous oesophageal Doppler - Velocity time integral (VTI) of left ventricular outflow tract (LVOT) - Passive leg raising test 5. Is the organ/ tissue perfusion adequate? - Capillary refill time - Serum lactate - Mottling score
  • 41.
  • 42.
  • 43. ICU Delayed admissions of critically ill patients from ED are associated with decreased sepsis bundle compliance and increased mortality, ventilator duration, and ICU and hospital length of stay
  • 45. CONCLUSION • Sepsis is a life-threatening organ dysfunction due to a dysregulated host response to infection. • Sepsis and septic shock are medical emergencies, treatment should be started immediately upon recognition. •Initial resuscitation and antibiotics should be given within 1 hour (infection present) •Adequate fluid resuscitation and early starting of vasopressor to prevent overloading and achieve target MAP faster. • Keep MAP > 65 mmHg •ICU admission within 6 hours is recommended.

Editor's Notes

  1. When a similar process occurs in response to a non-infectious condition (eg, pancreatitis, trauma), the process is referred to as systemic inflammatory response syndrome (SIRS). • Sepsis can be conceptualized as malignant intravascular inflammation. • Malignant because it is uncontrolled, unregulated, and self-sustaining • Intravascular because the blood spreads mediators that are usually confined to cell to-cell interactions within the interstitial space • Inflammatory because all characteristics of the septic response are exaggerations of the normal inflammatory response
  2. The complement system plays an invaluable role in promoting and coordinating the inflammatory process that is triggered in response to pathogens. The anaphylatoxins C3a and C5a are actively involved in the regulation of various critical events during an inflammatory response, such as changes in vascular flow and blood vessel calibre, increased vascular permeability, and leukocyte extravasation and chemotaxis [5]. These processes are essential for recruiting and activating the cells that are involved in the innate immune response, including neutrophils, monocytes and macrophages Host genetic variability in the regulatory and coding regions of genes for components of the innate immune system may influence the susceptibility to and/or outcome from sepsis. 
  3. Low threshold of suspicion and early recognition of sepsis are essential for successful outcomes
  4. ABCDE
  5. PCT concentrations increase earlier and normalize more rapidly than CRP, PCT has the potential advantage of earlier disease diagnosis, as well as better monitoring of disease progression.[9] Moreover, a number of studies have shown that the systematic use of PCT for sepsis diagnosis and monitoring may also have a positive impact on the reduction of antibiotic (AB) treatment, therefore allowing a shorter stay in the ICU and lower costs per case. This will also be beneficial in combating the increase of antibiotic-resistant micro-organisms which is mainly related to the excess use of antibiotics.[10,11,12,13] Additionally, researchers found a ≥30% decrease in PCT levels between days 2 and 3 to be an independent predictor of survival in ICU patients
  6. Quick SOFA • Out-of-hospital, ED, general medical ward • Patients with suspected infection who are likely to have a prolonged ICU stay or to die in hospital can be promptly identified at the bedside with qSOFA • Non-invasive, speed, repeatability to re-assess patient
  7. NEW RECOMMENDATION BY SSC IN 2021 – HOUR 1 BUNDLE TO REPLACE HOUR 3 AND HOUR 6 BUNDLE